Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumQinghaosu (Artemisinin): The Price of SuccessDeclining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand borderPfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaArtemisinin Resistance in Plasmodium falciparum MalariaMolecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug ProductionMathematical Modelling to Guide Drug Development for Malaria EliminationFocused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, CambodiaPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern CambodiaThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites.Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007The Jeremiah Metzger lecture: new additions to the toolbox for global malaria eradication.Emerging artemisinin resistance in the border areas of Thailand.Artemisinin Antimalarials: Preserving the "Magic Bullet"In vivo parasitological measures of artemisinin susceptibilityMultiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in CambodiaDiscovery, mechanisms of action and combination therapy of artemisininDried whole-plant Artemisia annua slows evolution of malaria drug resistance and overcomes resistance to artemisinin.Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover studySpread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquineIn vivo antimalarial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical AssessmentEx Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia.Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reactionThe efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia.Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.Management of uncomplicated malaria in underfives in private and public health facilities in South-eastern Nigeria: a clinical audit of current practices.Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy studyEfficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.
P2860
Q21032477-F1D2E220-726A-463F-BE46-601FCBADCE01Q21032496-F773B068-5566-445F-94F9-72455F64BE3EQ21032539-2DFED253-1A44-445D-9343-B15A425CD25EQ21034146-B472AE86-2C7B-4651-933A-EF31AC596F41Q22061852-625821B5-9174-4B17-88B0-219AC894AA20Q26752273-0F71FE04-69F1-4EF8-BE5C-7C3BCA3A6D29Q28067367-CE3613BB-43F4-4033-8455-95633643377FQ28484164-D3563F88-1F10-44A2-88EA-4F4BCFD0AE79Q30240158-462DCEC6-4788-46F7-A9B4-8C8A2C9504B3Q30379780-8B0430E6-C286-42E7-87A0-E5D85BBFCC97Q33399259-58E9E599-7A8A-4665-9C6B-B259E76C2711Q33655603-0BB4C8C7-B87E-4F6A-BDCF-BA4B555A5C91Q33693947-753EB6BC-E52E-4BD7-A638-41D1DAADE044Q33723453-3440A2CD-9784-4D29-B535-7730C749A006Q33785789-DED8614B-6076-4806-8F6F-99A6A78D9A3BQ33826378-6C25EB37-0E32-4639-B95E-2697AD09A53FQ33957657-8E765373-314D-4A39-ACCE-ADB9DFA14706Q34343530-FF59E8B7-FAFD-4131-B33A-2849216AB0A9Q34622342-40E2798A-0BD9-4634-B172-DC4E59E16BAAQ34921155-6FAD7C4D-8421-430A-BCCD-81176A712042Q34986023-DBA44991-00F1-42F1-A394-E2A16E40943CQ35006418-39F28144-18A2-46CB-8A99-4C42F8EA7C8EQ35031523-D06F3299-D3A8-46F0-B95B-E40BE6EAD90BQ35056250-BF198BD6-918F-476D-82EE-8497E7DEC6D7Q35217991-407CAD3D-AED8-4180-AF69-076B60A024C4Q35299140-BE805255-90EB-4825-985C-8217CABC6A3FQ35385674-1AA669F4-6873-4A55-A5D3-DA1CA76646E8Q35815377-F5C8F13F-A09A-4921-B87E-C01F31A65A69Q35859839-24F2B42B-4EA1-4C2B-9602-344C91368F00Q35859975-0812B67F-BB15-4545-BC44-9377E4877424Q35954244-1698E261-B9D5-4DB7-B36F-140D318BE6BAQ35991544-1EE98802-BEE6-45DD-9980-7091FFB25461Q36138872-192D073C-DABD-48F1-B58D-03C533ABC598Q36320208-3EFAE977-1CF6-4DEF-AE3B-4A4AC02ED696Q36338542-C3816B64-E3A4-48F9-AD81-7B2D83F36C5AQ36512312-B8C610F8-5150-4CC0-8B39-91D3BA0CFF62Q36558557-2DA4B671-D85E-40C0-A0BB-A18205C1C028Q36587265-9CE7FE3F-213D-421E-80AF-F716990CFFE0Q36749208-051EA25E-C473-4D23-8DA4-04C67045FD87Q37023329-390B867F-28FC-4876-A5B6-BEFEA40D9FB3
P2860
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@ast
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@en
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@nl
type
label
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@ast
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@en
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@nl
prefLabel
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@ast
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@en
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@nl
P2093
P2860
P921
P1476
Surveillance of the efficacy o ...... alciparum malaria in Cambodia.
@en
P2093
Duong Socheat
Eva Maria Christophel
Mey Bouth Denis
Pascal Ringwald
Reiko Tsuyuoka
Suon Seila
Top Sophoan Narann
Yi Poravuth
P2860
P304
P356
10.1111/J.1365-3156.2006.01690.X
P577
2006-09-01T00:00:00Z